Molecular epidemiology of smoking and lung cancer.

作者: Peter G Shields

DOI: 10.1038/SJ.ONC.1205832

关键词: CarcinogenesisInternal medicineRespiratory diseaseNicotineTobacco smokeOncologyCarcinogenToxicologyLungLung cancerAdenocarcinomaBiology

摘要: Lung cancer is the single most common cause of death, and almost all it due to tobacco smoking. Before widespread use cigarettes in this century, lung was a rare illness. Tobacco smoke complex mixture numerous mutagens carcinogens. Over last 40 years, type frequently used has been changing, namely increased low tar nicotine cigarettes. This accompanied by an risk smokers' need maintain blood levels, which turn causes for smoking more per day deeper inhalation. phenomena led increasing rates adenocarcinoma, compared squamous cell carcinoma. It also probably explains, part, greater women men (in addition some biological differences). The study involves many types biomarkers, including those that measure exposure, biologically effective dose harm. these allowed us understand parts carcinogenesis. Genetic susceptibilities play large role risk. They govern behavior (affecting dopamine reward mechanisms metabolism), carcinogen metabolism detoxification, DNA repair, cycle control other cellular responses. highlighted improve cessation reduce exposure among persons who cannot quit smoking, better prevention strategies former smokers understanding environmental

参考文章(99)
Aage Haugen, David Ryberg, Allan Hewer, David H. Phillips, Steen Mollerup, Sex Differences in Lung CYP1A1 Expression and DNA Adduct Levels among Lung Cancer Patients Cancer Research. ,vol. 59, pp. 3317- 3320 ,(1999)
Kei Nakachi, Kazue Imai, Kaname Kawajiri, Shin Ichi Hayashi, Polymorphisms of the CYP1A1 and Glutathione S-Transferase Genes Associated with Susceptibility to Lung Cancer in Relation to Cigarette Dose in a Japanese Population Cancer Research. ,vol. 53, pp. 2994- 2999 ,(1993)
G D Stoner, C S Yang, Z Guo, F J Gonzalez, T J Smith, F P Guengerich, Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human lung and liver microsomes and cytochromes P-450 expressed in hepatoma cells. Cancer Research. ,vol. 52, pp. 1757- 1763 ,(1992)
Gary D. Stoner, Chung S. Yang, Theresa J. Smith, Activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human lung microsomes by cytochromes P450, lipoxygenase, and hydroperoxides. Cancer Research. ,vol. 55, pp. 5566- 5573 ,(1995)
Aage Haugen, Alan Hewer, David Ryberg, David H. Phillips, Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Research. ,vol. 54, pp. 5801- 5803 ,(1994)
Carrie L. Hayes, Shantu Amin, Tsutomu Shimada, Hiroshi Yamazaki, Thomas R. Sutter, Thomas R. Sutter, F. Peter Guengerich, F. Peter Guengerich, Stephen S. Hecht, Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1 Cancer Research. ,vol. 56, pp. 2979- 2984 ,(1996)
K E Warner, L A Loeb, J Laszlo, V L Ernster, J Abbotts, Smoking and Lung Cancer: An Overview Cancer Research. ,vol. 44, pp. 5940- 5958 ,(1984)
Alaa F. Badawi, Douglas A. Bell, Nicholas P. Lang, Ari Hirvonen, Fred F. Kadlubar, Role of Aromatic Amine Acetyltransferases, NAT1 and NAT2, in Carcinogen-DNA Adduct Formation in the Human Urinary Bladder Cancer Research. ,vol. 55, pp. 5230- 5237 ,(1995)
John C. Bailar, Passive smoking, coronary heart disease, and meta-analysis. The New England Journal of Medicine. ,vol. 340, pp. 958- 959 ,(1999) , 10.1056/NEJM199903253401211
S. Kato, E. D. Bowman, A. M. Harrington, B. Blomeke, P. G. Shields, Human Lung Carcinogen—DNA Adduct Levels Mediated by Genetic Polymorphisms In Vivo Journal of the National Cancer Institute. ,vol. 87, pp. 902- 907 ,(1995) , 10.1093/JNCI/87.12.902